Clinical Trial Results: TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial results report on safety and tolerability of low-dose linezolid in multi-drug resistant and extensively drug-resistant tuberculosis (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multi-drug Resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-07-06